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Abstract
Background: Vascular branching morphogenesis is responsible for the extension of blood vessels
into growing tissues, a process crucial for organogenesis. However, the genetic mechanism for
vessel branching is largely unknown. Zebrafish reg6 is a temperature-sensitive mutation exhibiting
defects in blood vessel branching which results in the formation of swollen vessel lumina during
capillary plexus formation.
Results: We performed a screening for chemical suppressors of reg6 and identified SKF91488, an
inhibitor of histamine methyltransferase (HMT), that can rescue the reg6 vessel branching defects
in a dose-dependent manner. Inhibition of HMT by SKF91488 presumably blocks histamine
degradation, thus causing histamine accumulation. Consistent with this idea, we found that a high
level of histamine also showed significant suppression of reg6 vessel phenotypes. Interestingly, when
reg6 adults that had already developed swollen vessel lumina in regenerating fins were treated with
histamine or SKF91488, either treatment significantly reduced the number of swollen vessels within
12 h, suggesting a rapid and constant influence of histamine on blood vessel branching.
Furthermore, the expression of HMT was significantly elevated in reg6  regenerating fins.
Conversely, lowering histamine by administering urocanic acid, a histidine decarboxylase inhibitor,
enhanced the reg6 phenotypes. Finally, we identified that the transcription factor, egr-1 (early
growth response factor 1), was closely associated with the reg6  phenotype and chemical
treatments.
Conclusion: Taken together, our results suggest that blood vessel branching is influenced by
histamine metabolism, possibly through regulating the expression of the egr-1 transcription factor.
Background
Blood vessels are important for transporting oxygen and
nutrients to cells for survival and proper functioning. In
early embryos, the pioneer trunk vessels, the dorsal aorta
and cardinal vein, develop from vascular endothelial cells
derived from the lateral plate mesoderm through a proc-
ess called vasculogenesis. Subsequently, blood vessels
grow from existing vessels, through a process referred to as
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angiogenesis, into peripheral tissues and developing
organs [1]. In developing embryos, increasing evidence
has revealed that blood vessels also provide signals for the
proper morphogenesis of developing organs [2]. In the
adult form of organisms, angiogenesis and/or vasculogen-
esis to regrow blood vessels in wounded tissues is needed
to repair damaged and replace lost tissues [3,4]. In
humans, it has been well documented that angiogenesis
plays a vital role in tumor growth, and thus the potential
of antiangiogenesis drugs to inhibit tumor growth has
been extensively explored worldwide [5].
During angiogenesis, vascular branching is one of the key
morphogenetic events, which presumably is responsible
for constructing a complex vascular network which
assures that blood is available to every single cell. Despite
its important role in sustaining organismic development
throughout life, the genetic mechanism of blood vessel
branching is largely unknown partly due to the intricate
interactions between molecular signals and numerous cell
types that are involved in angiogenesis, e.g., multiple cel-
lular activities, including cell proliferation, migration,
extension, and possibly cell fate specification all of which
require signaling through multiple growth factors such as
VEGF, FGF, PDGF, and EGF. Interactions between blood
vessel endothelial cells and neighboring cells and even
cells in the bloodstream can also regulate angiogenesis
[6]. More recently, it has been implied that immune-
mediated cells and molecules can influence blood vessel
growth in adults. For example, mast cells have been found
to aggregate at sites of active angiogenesis under both
physiological and pathological conditions [7]. Histamine
has been determined to be an angiogenic factor [8,9] and
is thought to be directly involved in tumor growth based
on findings of high expression levels and enzymatic activ-
ity of the key histamine synthesis enzyme, histidine decar-
boxylase, in numerous growing tumors, such as small-cell
lung carcinoma [10,11]. In fact, clinical trials have shown
that histamine H2 receptor antagonists, such as cimeti-
dine and ranitidine, increase the survival of gastric and
colon cancer patients [12,13]. It has also been reported
that histamine regulates angiogenesis at the level of cell
proliferation and cell permeability [14,15]. Thus, hista-
mine seems to be involved in multiple cellular and molec-
ular interactions during angiogenesis. It is still unclear
whether histamine can influence blood vessel branching
during angiogenesis, and if it does, through which intrac-
ellular signaling pathway it works.
In this report, we took a chemical genetic approach to
reveal the role of histamine in vascular branching using a
zebrafish  reg6  mutation which causes specific vascular
branching defects without affecting endothelial cell prolif-
eration [16]. We show that vessel branching defects in reg6
mutants can be rescued by a high level of histamine either
directly added to the water or by inhibiting histamine deg-
radation using a histamine methyltransferase (HMT)
inhibitor. On the other hand, blocking histamine synthe-
sis by a histidine decarboxylase inhibitor enhanced the
reg6 vessel phenotypes. Finally, we show that the expres-
sion level of the egr-1 transcription factor, but not the
VEGF family, is strongly correlated with the reg6 pheno-
types, suggesting that histamine might modulate blood
vessel branching by regulating egr-1 levels.
Results
Specific blood vessel branching defect of the zebrafish 
reg6 mutation
The zebrafish reg6 mutation was isolated by its defects
during caudal fin regeneration [17]. It was previously
shown that the reg6 mutation causes blood vessel dilation
during plexus formation of vessel regeneration due to
defects in blood vessel branching, not in cell proliferation
[16]. Herein, we further tested whether the reg6  vessel
branching phenotype might be due to or might cause the
cell migration defect by measuring the distance endothe-
lial cells were able to migrate at different stages of blood
vessel regeneration. Upon amputation, blood vessels
undergo wound healing to seal the ends within the first 24
h followed by sprouting to reconnect the severed vessels
and resume blood circulation at the amputation site.
Blood vessel endothelial cells then proliferate and begin
to migrate into the regenerating tissues to form a vascular
plexus [16]. We found that regenerating endothelial cells
in both wild-type and reg6 fish are able to migrate more
than 0.35 mm within 2 days post amputation (dpa) (Fig-
ure 1A, B, I) when the swollen vessel lumen phenotype
has just begun to develop (Figure 1B, yellow arrows), sug-
gesting that vessel dilation is not due to a cell migration
defect. When the same fish were measured again at 3 dpa,
we found that endothelial cells in reg6 fish had migrated
more than 0.8 mm, which was similar to that in wild-type
fish (Figure 1I) despite significantly swollen vessels hav-
ing developed (Figure 1D, F, yellow arrows). Thus, the for-
mation of swollen vessel lumina in reg6 fish does not
seem to cause cell migration defects, at least up to 3 dpa.
Cross-sections of reg6 regenerating fins revealed enlarged
lumina in most of the regenerating vessels (Figure 1H,
arrows).
To understand the cellular defects in angiogenic endothe-
lial cells of reg6 mutants, we examined the cell integrity by
whole-mount and transmission electron microscopy
(TEM). We first noted that the permeability of reg6
endothelial cells seemed defective as leaked blood cells
were often observed in reg6 regenerating fins (Figure 2B,
G). In addition, while endothelial cells stretch thin and
form tight junctions and intact enclosed blood vessels of
different sizes in wild-type regenerating fins (Figure. 2C, E
and Additional file 1), reg6  endothelial cells did notBMC Developmental Biology 2008, 8:31 http://www.biomedcentral.com/1471-213X/8/31
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appear as stretched-out as those in the wild-type and sel-
dom formed obvious tight junction (Figure 2D, F and
Additional file 2). Taken together, our current and previ-
ous [16] results suggest that reg6 function is specifically
required for cell elongation and the formation of tight
junctions between endothelial cells that are essential for
blood vessel branching morphogenesis.
Isolation of a chemical suppressor of the reg6 mutation
A similar swollen-vessel phenotype was also observed in
developing caudal veins of reg6 mutants during embryo-
genesis (Figure 3; [16]). In wild-type embryos, the poste-
rior cardinal vein branches to form a transient capillary
plexus beginning at around 30 h post fertilization (hpf)
(Figure 3A, C; [18]), which is typically located ventral to
the dorsal aorta in the tail and is comprised of 2 or 3 par-
allel yet interconnected vessels (Figure 3E, F). In reg6
mutants, however, the caudal vein forms fewer branches
and develops a large swollen vascular lumen (Figure 3B,
D, G, H). The reg6 mutation is temperature sensitive caus-
ing up to 70% penetrance of its embryonic phenotypes at
33°C (Figure 4E) and 0%~5% at 20°C (not shown). The
temperature sensitivity of its regenerating vessel pheno-
type is described below (see also [16]). Taking advantage
of the incomplete penetrance of the reg6 embryonic phe-
notype, we initiated a screening to search for chemical
suppressors and enhancers of reg6 mutation. We tested a
small collection of known compounds using reg6-
homozygous embryos (see "Methods"). Of the 560 tested
chemicals, one showed significant suppression of reg6
phenotypes in developing caudal veins at a concentration
of 10 μM (Figure 4C, D). This chemical, 4-(N, N-dimeth-
ylamino) butylisothiourea dihydrochloride (SKF91488),
is an inhibitor of HMT, the major enzyme responsible for
histamine degradation [19]. To test the specificity of
SKF91488 on reg6 vessel phenotypes and its cytotoxicity
to developing embryos, we treated reg6  and wild-type
embryos with different concentrations of the compound.
The results showed that suppression was dose-dependent,
and the penetrance of the reg6  embryonic phenotype
could be reduced to 20% by 50 μM SKF91488 (Figure 4E).
The HMT inhibitor caused no morphological defects or
vessel over-branching in wild-type embryos at as high as
100 μM (data not shown).
Suppression of the reg6 embryonic phenotype by a high 
level of histamine
As HMT is responsible for methylating histamine thus
precipitating its degradation, the above results led us to
hypothesize that SKF91488 might cause accumulation of
histamine, which in turn would rescue reg6 phenotypes.
We tested this hypothesis by treating reg6 embryos with
histamine. The results showed that a high level of hista-
mine indeed was able to rescue the embryonic pheno-
types of reg6  mutants, although the concentration of
Normal migration of regenerating endothelial cells in  zebrafish reg6 mutants Figure 1
Normal migration of regenerating endothelial cells in 
zebrafish reg6 mutants. (A, B) Combined bright field and 
green fluorescent images of wild-type TG(fli1:EGFP)y1 (A) and 
reg6;TG(fli1:EGFP)y1 (B) regenerating fins at 2 days post ampu-
tation (dpa) showing the distance (designated by white dou-
ble arrows) that the blood vessel endothelial cells (ECs) have 
migrated. Yellow arrows, dilated vessels of reg6 mutants. (C-
F) In 3-dpa regenerates, wild-type fish have formed normal 
capillary plexuses (C, yellow arrows in E)., but reg6 fish (D, 
bright field; F, green fluorescent) have developed numerous 
swollen vessels (yellow arrows in D and F) resulting in blood 
cell accumulation (red spots in D). (G, H) Cross-sections of 
3-dpa regenerates showing normal regenerating vessels in 
wild-type (G) and dilated vessels in reg6 fish (H, yellow 
arrows). Red arrows, amputation plane. Scale bars, 300 μm. 
(I) Quantitative data of the migration distance of regenerating 
ECs in wild-type (black bars) and reg6 fish (white bars) at 2 
and 3 dpa.BMC Developmental Biology 2008, 8:31 http://www.biomedcentral.com/1471-213X/8/31
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histamine needed to produce significant suppression was
1000 μM (Figure 4E, green bars). Like the HMT inhibitor,
a high level of histamine caused no discernible develop-
mental defects in wild-type zebrafish embryos (data not
shown).
Suppression of the reg6 regenerating vessel phenotype by 
SKF91488 and histamine
As shown before, the blood vessel phenotype in regener-
ating reg6 fins develops swollen vessel lumina at a high
temperature (33°C). To further confirm the effect of his-
tamine on reg6 vessel branching defects, we treated regen-
erating vessels of reg6  and wild-type adult fish with
histamine and SKF91488. Consistent with the results
obtained from embryos, the regenerated swollen vessel
lumen phenotype in reg6 fish was both quantitatively and
qualitatively suppressed by 10 μM SKF91488, as treated
ones formed fewer and smaller blood blisters than their
untreated siblings (Figure 5A–C). We then tested whether
histamine can also rescue the reg6 phenotype in regener-
ating vessels. In fact, 1 mM histamine did suppress the
reg6 regenerating vessel phenotype (data not shown). We
noted that while most stocks of reg6  formed swollen
lumina in 15 vessels/fish on average at 33°C (Figure 5E,
H2O group), some stocks possibly formed 7 swollen ves-
sels/fish (Figure 5C, H2O group). But within the same
inbred family, the penetrance was less variable (CC
Huang, unpublished observations). Therefore, we were
careful to use fish of the same stock for making compari-
sons. These results suggested that increasing the histamine
level can rescue the blood vessel branching defect of
zebrafish reg6 mutants.
The above results led us to hypothesize that the expression
of HMT might increase in reg6 mutants, which is respon-
sible for the histamine deficit. To test this, we analyzed the
amount of HMT RNA in wild-type and reg6 regenerates by
quantitative PCR (QPCR). We found that the amounts of
HMT RNA were nearly 5- and 3-fold higher in reg6 2 and
3-dpa regenerates, respectively, than in wild-type ones
(Figure 5D).
Reversion of reg6 dilated vessels by histamine and 
SKF91488
We wondered whether histamine and SKF91488 are able
to reduce the severity of the vessel phenotype in reg6
mutants even after significant swollen vessels had formed.
To test this, we first allowed reg6 mutants to regenerate at
Cellular defects of reg6 endothelial cells Figure 2
Cellular defects of reg6 endothelial cells. (A, B) Overlaid images of bright field and green fluorescent protein (GFP) of 
wild-type (A) and reg6 (B) 3-dpa regenerating fins showing the leakage of blood cells in reg6 fish (arrows). Transmission elec-
tron microscopic images of wild-type fish (C, low magnification; E, high magnification) showing that the blood vessel is enclosed 
by several endothelial cells which form nice, intact tight junctions (arrow in E). Additional images can be found in Additional file 
1. In contrast, the blood vessels in reg6 fish (D) were usually leaking as evidenced by the lack of coverage by endothelial cells 
(arrow) and the presence of blood cells outside blood vessels (as an endothelial cell is sandwiched by two blood cells in G and 
arrows in Additional file 2). In addition, reg6 endothelial cells appeared less stretched-out (D), and tight junction were rarely 
formed among them (F). Scale bars, 2 μm for C, D, F, and G; 10 nm for E. white asterisks, blood cell; black asterisks, endothe-
lial cell.BMC Developmental Biology 2008, 8:31 http://www.biomedcentral.com/1471-213X/8/31
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33°C for 3 days to develop swollen lumina, and then
shifted them to either 10 μM SKF91488, 1 mM histamine,
or H2O. We then compared the number of swollen vessels
before and then 12 h after the shift. In the H2O group, the
number of swollen vessels in reg6 fish was about the same
within the 12-h period: near 20 swollen vessels/fish (Fig-
ure 5E). With SKF91488 treatment, however, the number
of swollen vessels was significantly reduced to an average
of 10 swollen vessels/fish (Figure 5E, P < 0.01, n = 10).
Histamine also reduced the number from 20 to fewer than
15 (P = 0.03, n = 10). In the distal portions of regenerating
fins of reg6 adults, the vessel defects usually caused necro-
sis and degeneration, which were thus greatly reduced by
histamine and SKF91488 (data not shown). We con-
cluded that a high level of histamine can reverse the swol-
len vessel phenotype of the reg6 mutation.
Enhancement of the reg6 regenerating vessel phenotype 
by a histamine synthesis blocker
To further verify the role of histamine in promoting blood
vessel branching, we next tested whether blocking hista-
mine synthesis could enhance reg6  vessel branching
defects. As stated before, the reg6 mutation is temperature
sensitive. At a low temperature (20°C), the number of
swollen vessels in reg6 regenerates was nearly zero (Figure
6). We treated reg6 regenerating vessels at this temperature
with urocanic acid, one of the inhibitors of histidine
decarboxylase which is the key enzyme for histamine syn-
thesis. The results showed that the number of swollen ves-
sels in 3-dpa reg6 regenerating fins at 20°C was about 1.9
± 1.5/fin (n = 10), and this increased to 6.9 ± 2.9/fin (n =
9) with 300 μM urocanic acid (Figure 6A and 6B for mor-
phological comparisons and C for quantitative data). A
similar effect was also observed at 6 dpa during plexus for-
mation of regeneration at 20°C (Figure 6C). Note that fin
regeneration was much slower at 20°C than at 33°C, and
regeneration at 3 and 6 dpa at 20°C corresponded to the
vessel anastomosis and plexus formation stages of vessel
regeneration, respectively, both of which are affected by
the reg6 mutation [16]. Urocanic acid at 300 μM caused
no reg6-like phenotype or toxicity in wild-type adult fish
(data not shown).
Histamine synthesis blocker causes blood vessel branching 
defect in wild-type zebrafish embryos
To address whether histamine also influences blood vessel
branching in wild-type fish, we treated the wild-type
TG(fli1:EGFP)y1 developing embryos with urocanic acid.
In these experiments, we focused on the effect of urocanic
acid on the caudal veins which normally form highly
branched vascular plexuses during 30–48 hpf of the devel-
opment (Figure 7A). Among the several doses and treating
conditions that we tried, we found that 300 μM of uro-
canic acid, treated from 6–32 hpf, had no effect on the
caudal vein development or the survival rate whereas 900
μM of urocanic acid could cause slightly increase of less
branched caudal veins and more than 50% of lethality
(data not shown). However, shorter treatment from
26–32 hpf with 900 μM urocanic acid caused lower
lethality rate but significantly increase of poorly branched
caudal veins (Figure 7B, C). These results demonstrate
that blocking histamine synthesis indeed hampers blood
vessel branching in wild-type zebrafish embryos.
Association between egr-1 expression and the reg6 
vascular phenotype
To test whether VEGF is involved in the mechanism for
suppressing reg6 blood vessel branching defects by hista-
mine, we performed QPCRs to examine the expression
levels of known VEGFs and their receptors and some
known angiogenic factors in wild-type and reg6 regenerat-
ing fins. We found no correlation between VEGF signaling
and the reg6  phenotype, as the expression levels of
zebrafish VEGF-A, C, and D, and VEGFR1, 2, and 3 were
approximately the same in both wild-type and reg6 fish
(Figure 8A and Additional file 3). Interestingly, we found
that the level of egr-1, which is known to be involved in
angiogenesis [20] was downregulated in reg6 fish (Figure
Embryonic phenotype of the reg6 mutation Figure 3
Embryonic phenotype of the reg6 mutation. (A, C) In a 
36-hpf (hours post fertilization) wild-type embryo (A, bright 
field; C, green fluorescent), the developing caudal veins form 
vascular plexuses (yellow arrow in C). (B, D) In contrast, 
endothelial cells of reg6 embryos (B, bright field; D, green flu-
orescent) develop fewer vessel branches and form swollen 
lumina (yellow arrows). Lateral view; anterior, left; dorsal, 
top. Scale bar, 100 μm for A-D. (E-H) Cross-sections of the 
tail regions showing multiple lumina of the capillary plexus of 
a wild-type caudal vein (E, yellow arrows in F) but a single 
enlarged lumen in reg6 (G, yellow arrow in H). N, noto-
chord; white arrows, dorsal aorta; yellow arrows, caudal 
vein; red arrow, accumulated blood cells.BMC Developmental Biology 2008, 8:31 http://www.biomedcentral.com/1471-213X/8/31
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8A). Whole-mount in situ hybridization also showed a
significant decrease in egr-1 expression in reg6  3-dpa
regenerating fins (Figure 8C). More importantly, the
expression of egr-1 in reg6 mutants was found to be ele-
vated by approximately 2.5-fold after treatment with 1
mM histamine or 10 μM SKF91488 and downregulated by
urocanic acid, compared with water-treated siblings (Fig-
ure 8D). In contrast, expression levels of VEGFs and their
receptors did not change or changed by less than 2-fold
after treatment with histamine, SKF91488, or urocanic
acid (Additional file 4). These results suggest that hista-
mine might promote blood vessel branching by regulat-
ing egr-1 expression directly or indirectly. Note that this
correlation was only found in adult fish, not in embryos
(data not shown), suggesting that histamine might influ-
ence regenerative and embryonic angiogenesis through
different mechanisms.
Discussion
Zebrafish angiogenesis mutation for drug discovery and 
chemical genetics
We utilized a zebrafish mutation to demonstrate the
power of zebrafish for drug discovery and examining
chemical genetics. In particular, when using the embry-
onic phenotype for initial screening, which only required
0.5 μg of the test compound (with a MW of 250), the
adult phenotypes, if they existed, allowed us to verify the
drug effect with only 5 μg of drug for each test (see also
"Methods"). In conjunction with TG(fli1:EGFP)y1 trans-
genic fish, the screening could be specifically targeted for
angiogenesis-related drugs (see also [21]). In addition,
with zebrafish, we were able to perform toxicity tests at the
same time at the whole organism level. All these factors
make zebrafish a great tool for drug testing and discovery.
The reg6 mutation is unique in that it is homozygously
Suppression of the reg6 embryonic phenotype by SKF91488 and histamine Figure 4
Suppression of the reg6 embryonic phenotype by SKF91488 and histamine. (A, bright field; B, GFP) Untreated reg6 
embryos developed dilated caudal veins at 33°C (yellow arrows). (C, bright field; D, GFP) reg6 embryos treated with 10 μM 
HMT inhibitor SKF91488 developed normal caudal veins. Anterior, left; dorsal, top. (E) Typically, almost 70% of reg6 embryos 
formed dilated caudal veins at 33°C (blue bar). The penetrance was reduced by SKF91488 (red bars, n = 50) and histamine 
(green bars, n = 50).BMC Developmental Biology 2008, 8:31 http://www.biomedcentral.com/1471-213X/8/31
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viable and displays similar blood vessel branching defects
during embryogenesis and fin regeneration. More impor-
tantly, the reg6 mutation has the advantage of tempera-
ture sensitivity which allowed us to screen for suppressors
and enhancers. Since reg6 mutants display specific defects
in blood vessel branching, it has become a good tool for
studying the genetic and pharmacological mechanisms of
vessel branching which are largely unknown.
The role of histamine in blood vessel branching in reg6 and 
wild-type zebrafish
Our results reveal a role of histamine in promoting vessel
branching during angiogenesis using zebrafish reg6
mutants. The reg6 mutants were found to have specific
defects in blood vessel branching during plexus formation
[16]. When reg6  mutants were treated with the HMT
inhibitor, SKF91488, which presumably causes accumula-
tion of histamine, or with a high level of histamine, the
blood vessel branching defect of reg6 was significantly res-
cued. In contrast, blocking histamine synthesis enhanced
the reg6 phenotype. These results were further supported
by the finding that HMT expression is elevated in reg6
mutants. All these suggest a simple model for the reg6
blood vessel branching defect which results from a high
level of HMT and concomitant histamine deficit.
The role of histamine in regulating blood vessel branching
is also observed in wild-type zebrafish. In Figure 7, we
showed that blocking histamine synthesis with urocanic
acid causes blood vessel branching defect and/or a reg6-
like phenotype in the caudal veins of wild-type zebrafish
embryos. In this experiment, however, we learned that it
really required high concentration and careful selection of
time window of urocanic acid treatment in order to see its
effect on blood vessel branching. Treatment of high con-
centration of urocanic acid for long period of time, e.g.
from 6–32 hpf caused high lethality rate in developing
embryos suggesting that histamine is important for other
Suppression of the reg6 regenerating vessel phenotype by SKF91488 and histamine Figure 5
Suppression of the reg6 regenerating vessel phenotype by SKF91488 and histamine. (A) reg6 regenerating vessels 
formed swollen lumina 3 days post amputation (dpa) at 33°C (yellow arrows). (B) In the presence of 10 μM SKF91488, reg6 
mutants developed significantly smaller and fewer swollen vessels (yellow arrows). Red arrows, amputation plane. (C) Quanti-
tative data of the suppression of reg6 regenerating vessels by SKF91488 (n = 5 for each group). This experiment was repeated 
at least 3 times, and consistent results were observed. (D) Quantitative polymerase chain reaction (QPCR) analyses showed 
elevated levels of histamine methyltransferase (HMT) RNA in both reg6 2 and 3-dpa regenerates compared with the wild-type. 
(E) Both SKF91488 and histamine could reverse the reg6 vessel phenotypes. The number of swollen vessels in reg6 mutants 
was counted at 3 dpa at 33°C (blue bars; B, before treatment) before they were transferred to either fresh water (H2O), 10 
μM SKF91488, or 1 mM histamine. The number of swollen vessels was counted again 12 h later (red bars; P, post-treatment). 
Shown is a representative set of data with 10 fish. Similar results were obtained from 2 independent experiments with different 
stocks of reg6 fish.BMC Developmental Biology 2008, 8:31 http://www.biomedcentral.com/1471-213X/8/31
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developmental processes. Furthermore, we noted that
urocanic acid did not seem to suppress the branching of
intersegmental vessels, suggesting that the influence of
histamine on vascular branching morphogenesis is selec-
tive or more sensitive for the plexus-forming blood ves-
sels.
Possible mechanisms of regulating blood vessel branching 
by histamine
As vascular branching involves complex intracellular and
extracellular changes, including breakdown of the extra-
cellular matrix and intercellular junctions, reorganization
of the cytoskeleton, and induction of cell proliferation, it
is difficult to predict the mechanism through which hista-
mine rescues vessel branching defects in reg6 fish. Even
though our phenotypic characterizations provide clues to
the specific endothelial cellular defects underlying reg6
vascular defects, including defects in cell extension, cell
junction formation, and likely permeability as well, it is
still not possible at this moment to define a cellular mech-
anism for the rescue effect of histamine in reg6 fish due to
the fact that the genetic identity of reg6  has yet to be
resolved. We have mapped reg6 to the telomere region of
LG 25 (CC Huang, unpublished results) where sequence
information is largely lacking, and thus, it is difficult to
obtain an accurate physical map. We are currently verify-
Blocking of histamine synthesis causes blood vessel branching  defects in wild-type zebrafish embryos Figure 7
Blocking of histamine synthesis causes blood vessel 
branching defects in wild-type zebrafish embryos. (A) 
In a 32 hpf wild-type embryo, the developing caudal vein 
formed a transient vascular plexus. (B) When treated with 
900 μM of the histamine synthesis blocker, urocanic acid, the 
caudal vein of a wild-type sibling formed much fewer vascular 
branches and even developed a reg6-like swollen lumen. Red 
arrows, caudal veins. (C) Quantitative results of the suppres-
sion of urocanic acid on blood vessel branching in wild-type 
zebrafish embryos. Two clutches of wild-type embryos (blue 
and red bars) were treated with the vehicle (0.0015 hydro-
chloric acid), or 300 or 900 μM of urocanic acid in egg water, 
from 26–36 hpf at 28.5°C. The percentage of embryos with 
less branched caudal vein was scored at the end of treatment 
(Y-axis, n = 40 unless otherwise specified).
Chemical enhancer of reg6 mutation Figure 6
Chemical enhancer of reg6 mutation. (A) reg6 is a tem-
perature-sensitive mutation and regenerates almost normally 
at 20°C. Shown is the regenerating vessels 6 days post ampu-
tation at 20°C. Note that they regenerated much more 
slowly at the low temperature. (B) When treated with 300 
μM of the histidine decarboxylase inhibitor, urocanic acid, 
reg6 siblings developed a significant number of swollen ves-
sels (yellow arrows). Red arrows, amputation plane. (C) The 
enhancement by urocanic acid of reg6 vessel defects was 
evaluated at two regenerative stages, during anastomosis (3 
dpa at 20°C, n = 10) and plexus formation (6 dpa at 20°C, n 
= 10) that are both affected by the reg6 mutation [16]. U300, 
300 μM of urocanic acid.BMC Developmental Biology 2008, 8:31 http://www.biomedcentral.com/1471-213X/8/31
Page 9 of 12
(page number not for citation purposes)
ing a physical map of that region assembled by the
Zebrafish Genome Sequencing Project at the Sanger
Center with our reg6 mapping panels. We will need to
build a more-accurate physical map of this region for
future mapping and cloning of the reg6 gene.
Nevertheless, we have obtained more clues to reg6's func-
tion from previous and the present studies. Our previous
study showed that the reg6 mutation does not cause over-
proliferation of regenerating endothelial cells and that
reg6 function is specifically required during plexus forma-
tion when blood vessel endothelial cells are actively
branching [16]. In this study, we further showed that the
reg6 mutation does not affect the migration of regenerat-
ing endothelial cells. Instead, endothelial cells of reg6
mutants seem to be defective in extending cell processes
and forming cell junctions among themselves. Our results
also suggest that reg6's function might be involved in reg-
ulating histamine metabolism and egr-1 expression. Con-
sistent with previous results, we observed no effect of
histamine on endothelial cell proliferation or migration
in wild-type fish, even though it has been shown that his-
tamine is able to cause endothelial cell proliferation in
vitro [11,14]. Our studies using the zebrafish reg6 muta-
tion provide evidence that histamine likely modulates
blood vessel branching at a yet unidentified cellular level
other than cell proliferation or migration.
Correlation of egr-1 and the vessel branching defects of 
reg6
It is very intriguing that we found a close relationship
between the egr-1 transcription factor and reg6 pheno-
types. The level of egr-1 was low in reg6 mutant fish dur-
ing regenerative angiogenesis, was elevated by histamine
and an HMT inhibitor, and was further reduced upon
treatment with a histamine synthesis blocker (Figure 8D).
Although the role of egr-1 and its relationship with hista-
mine in vascular branching awaits further studies, we
found an interesting feature of egr-1 in our studies that
s e e m  t o  e c h o  p r e v i o u s  f i n d i n g .  F a h m y  e t  a l  [ 2 0 ]  h a s
shown that egr-1 is required for angiogenesis and tumor
growth through an FGF but not a VEGF signaling path-
way. Our QPCR analyses showed that the transcription
levels of VEGFs and VEGFRs remained the same in wild-
type and reg6 fish with or without histamine manipula-
tions suggesting that the mechanism(s) of blood vessel
branching mediated by histamine that involves egr-1 is
independent of the VEGF signaling. It would be exciting to
know whether histamine modulates blood vessel branch-
ing directly through egr-1 and/or a FGF pathway.
Direct and indirect actions of histamine on blood vessel 
endothelial cells
Histamine has been shown to increase vessel permeability
by regulating the expression of cell adhesion molecules
such as VCAM [15] and the composition of the extracellu-
lar matrix [22]. Presumably, these actions together can
promote vessel branching. Our result that histamine can
Association of egr-1 expression and the reg6 vessel branching  defect Figure 8
Association of egr-1 expression and the reg6 vessel 
branching defect. (A) Expression levels of the egr-1 gene 
in wild-type (wt; black bars) and reg6 (white bars) 3-dpa 
regenerates. (B, C) Whole-mount in situ hybridization for 
egr-1 on wild-type (B) and reg6 (C) 3-dpa regenerates 
showed decreased expression of egr-1 in reg6 fish. Arrows, 
egr-1 RNA signal. (D) The egr-1 expression in reg6 mutants 
was upregulated more than 2.5-fold by 1 mM histamine and 
10 μM SKF91488 but was downregulated by 300 μM uro-
canic acid. The expression level was determined by QPCR 
and normalized by the expression level of the β-actin gene.BMC Developmental Biology 2008, 8:31 http://www.biomedcentral.com/1471-213X/8/31
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prevent the formation of swollen vessel lumina suggests
its influence on actively branching vascular cells. We also
showed that histamine can reverse the swelling of vessels
and return them to normal, suggesting a role of histamine
during vascular plexus remodeling. One possible explana-
tion for these results is that histamine affects a cellular
mechanism that is common to both vascular activities, for
example cell adhesion or extracellular matrix remodeling.
In fact, the histamine receptor inhibitor, cimitidine, has
been shown to downregulate the endothelial expression
of E-selectin adhesion molecules and prevent tumor
metastasis [23], which raises the possibility that histamine
might directly modulate vessel branching on endothelial
cells by regulating E-selectin expression. However, the fact
that histamine does not change endothelial cell prolifera-
tion or cause over-branching or any other morphological
changes in wild-type fish suggests that endothelial cells
are not the direct target of histamine. Thus, it is possible
that histamine might both directly and indirectly influ-
ence vascular branching.
Conclusion
We demonstrate the power of using a zebrafish mutation
in pharmacogenetic studies. Our studies using the
zebrafish reg6 mutation revealed the role of histamine in
regulating blood vessel branching and the potential link-
age of angiogenic factor egr-1 to this process.
Methods
Fish husbandry
Fish maintenance and breeding were performed accord-
ing to standard procedures [24].
Chemical screening with reg6 embryos
reg6 homozygous embryos were obtained by in vitro ferti-
lization for chemical screening of clones due to the con-
cerns that reg6  embryos from different clutches might
show variable degrees of phenotypic penetrance. Embryos
from different pairs of parents were kept separate, and 20
embryos from each individual clutch were set aside to
monitor the phenotypic penetrance. The protocol for
chemical treatment of zebrafish embryos was adapted
from Peterson et al. [25] with minor modifications. These
embryos were allowed to develop at 28.5°C until 6 h
post-fertilization (hpf) and then were arrayed into 96-well
plates, at 5 embryos/well with 200 μl of egg water (dis-
tilled water containing 60 μg/ml sea salt) without antibi-
otics. The LOPAC chemical library (Sigma, St. Louis, MO,
USA) was prepared at 2 mM in DMSO, and 1 μl of each
was added to each well to make 10 μM for our initial
screening. These plates were kept in a 33°C incubator and
examined at around 32 hpf with a fluorescent stereomi-
croscope. Chemicals used in this study were purchased
from Sigma unless otherwise signified.
Chemical treatment of adult fish
Adult fish were briefly anesthetized with 0.01% tricaine,
and the caudal fins were amputated vertically at 50% of
the proximal-distal axis. Five amputated fish were put into
a 250-ml beaker containing 100 ml of aquatic water with
or without chemicals. These fish were then kept in a 33°C
incubator for 3 days without feeding. With this protocol,
the wild-type fish could regenerate normally, while reg6
fish developed swollen vessel lumina. To quantify the reg6
phenotype, the number of vessels that developed obvi-
ously swollen lumina was determined. Since each fin ray
except for the two lateral fin rays contains three vessels
[16], 48 vessels of the 16 fin rays were examined and
scored for a typical caudal fin with 18 fin rays.
Transmission electron microscopy
Embryos were fixed in 2% glutaraldehyde, 2% parafor-
maldehyde, and 0.1 M sodium phosphate (pH 7.4) over-
night at 4°C. Fixed embryos were washed with 0.1 M
sodium phosphate buffer 3 times for 5 min each, and
post-fixed with 1% OsO4 for 1 h at room temperature. The
fixed embryos were dehydrated by the following ethanol
series: 30% for 10 min, 50% for 10 min, 70% for 20 min,
80% for 20 min, 90% for 20 min, 95% for 20 min, and
100% for 60 min, and then twice in acetone for 30 min
each. Infiltration was carried out first with 1:1 resin: ace-
tone for 1 h, 2:1 resin: acetone for 1 h, pure resin for 1 h,
and finally pure resin overnight. Embryos were placed in
a 70°C oven overnight for embedding. The plastic blocks
were then trimmed and sectioned to obtain 1 μm or
ultrathin section of 70~90 nm which were collected on
200-mesh copper grids and stained with uranyl acetate for
50 min and lead citrate for 10 min. Sections were analyzed
under a Hitachi H-7000 transmission electron microscope
equipped with AMT XR40 CCD camera (Advanced Micro-
scopy Techniques, Danvers, MA USA).
Whole mount in situ hybridization
Regenerative fins were harvested and fixed in 4% parafor-
maldehyde overnight at 4°C. The whole-mount in situ
hybridization was done with the InsituPro VS robot by
Intavis Bioanalytical Instruments AG (Koln, Germany)
following standard procedures of the manufacturer.
Quantitative polymerase chain reaction (QPCR)
Wild-type or reg6 homozygous embryos were treated with
chemicals for 26 h (from 6 to 32 hpf) or 8 h (from 24 to
32 hpf) at 33°C and then manually dechorionated at the
end of treatment. Fifty embryos from each treatment were
subjected to RNA extraction with Trizol following instruc-
tions of the manufacturer. Around 5 μg of total RNA was
then used to generate cDNAs with Superscript II (Invitro-
gen). Quantitative PCR was performed with a Power
Cybergreen (ABI) labeling kit in an ABI7000 thermocy-
cler. The data were analyzed with the software provided byBMC Developmental Biology 2008, 8:31 http://www.biomedcentral.com/1471-213X/8/31
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ABI. When using adult fish, five 3-dpa regenerative fins
from treated or untreated wild-type or reg6 fish were col-
lected.
Primers used for quantitative PCR were egr-1F, AGTTT-
GATCACCTTGCTGGAGATAC; egr-1R, AGGGTGAAACG-
GCCTGTGT; HMT-F, AATGAAGTGGTGGAACCA










GTCGGCCGTGTGGTTA; and VEGFR3-R, CGAATCCT-
TCAGGGATAGTGGTT.
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is found among these cells. B, blood cell; E, endothelial cell. Scale bar, 2 
μm.




Expression levels of VEGF related genes in wild-type and reg6 regenerative 
fins. The expression levels of VEGFC, VEGFD, VEGFR1, and VEGFR2 is 
about the same in wild-type (black bars) and reg6 (white bars) 3-dpa 
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is less than two folds. The expression level is determined by QPCR and 
normalized by the expression level of β-actin gene.




Expression levels of VEGF related genes in reg6 regenerative fins upon dif-
ferent treatments. The treatment of (1) H2O, (2) 1 mM histamine, (3) 
10 μM SKF91488, or (4) 300 μM urocanic acid does not alter signifi-
cantly the expression levels of VEGF-A, VEGF-C, VEGF-D, VEGFR1, 
VEGFR2, and VEGFR3 in reg6 3-dpa regenerates.
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